These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24581276)

  • 1. Improved real-world glycaemic outcomes with liraglutide versus other incretin-based therapies in type 2 diabetes.
    Lee WC; Dekoven M; Bouchard J; Massoudi M; Langer J
    Diabetes Obes Metab; 2014 Sep; 16(9):819-26. PubMed ID: 24581276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily in the treatment of type 2 diabetes.
    Alshali KZ; Karawagh AM
    Saudi Med J; 2016 Aug; 37(8):834-42. PubMed ID: 27464858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of switching from sitagliptin to liraglutide in subjects with type 2 diabetes (LIRA-SWITCH): a randomized, double-blind, double-dummy, active-controlled 26-week trial.
    Bailey TS; Takács R; Tinahones FJ; Rao PV; Tsoukas GM; Thomsen AB; Kaltoft MS; Maislos M
    Diabetes Obes Metab; 2016 Dec; 18(12):1191-1198. PubMed ID: 27381275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 Diabetes initiating injectable therapies.
    Wei W; Buysman E; Grabner M; Xie L; Brekke L; Ke X; Chu JW; Levin PA
    Diabetes Obes Metab; 2017 Mar; 19(3):375-386. PubMed ID: 27860158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emulating the GRADE trial using real world data: retrospective comparative effectiveness study.
    Deng Y; Polley EC; Wallach JD; Dhruva SS; Herrin J; Quinto K; Gandotra C; Crown W; Noseworthy P; Yao X; Lyon TD; Shah ND; Ross JS; McCoy RG
    BMJ; 2022 Oct; 379():e070717. PubMed ID: 36191949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemia and Gluconeogenesis With Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.
    Dietsche KB; Magge SN; Dixon SA; Davis FS; Krenek A; Chowdhury A; Mabundo L; Stagliano M; Courville AB; Yang S; Turner S; Cai H; Kasturi K; Sherman AS; Ha J; Shouppe E; Walter M; Walter PJ; Chen KY; Brychta RJ; Peer C; Zeng Y; Figg W; Cogen F; Estrada DE; Chacko S; Chung ST
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1361-1370. PubMed ID: 37967247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics.
    Marcum ZA; Driessen J; Thorpe CT; Donohue JM; Gellad WF
    Ann Pharmacother; 2015 Mar; 49(3):285-92. PubMed ID: 25515869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis.
    Wilke T; Mueller S; Fuchs A; Kaltoft MS; Kipper S; Cel M
    Diabetes Ther; 2020 Oct; 11(10):2357-2370. PubMed ID: 32876862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sitagliptin therapy on IL-29 and its associated signaling molecules in patients with type 2 diabetes mellitus.
    Nabiyi S; Sajedi F; Zamani A; Behzad M
    Hum Immunol; 2024 Jun; 85(4):110833. PubMed ID: 38897073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns and clinical characteristics of patients with type 2 diabetes mellitus according to body mass index: findings from an electronic medical records database.
    Weng W; Tian Y; Kimball ES; Kong SX; Bouchard J; Hobbs TM; Sakurada B
    BMJ Open Diabetes Res Care; 2017; 5(1):e000382. PubMed ID: 28761654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrinology/Primary Care Pharmacy Collaboration vs Endocrinology Care Alone in Patients With Type 2 Diabetes and A1c >9.
    Fornwald CR; Russo-Alvarez G; Pantalone KM; Zeleznikar E; Parker M; McCorkindale N; Butler R; Hermiller T
    J Pharm Technol; 2024 Apr; 40(2):78-84. PubMed ID: 38525094
    [No Abstract]   [Full Text] [Related]  

  • 12. Liraglutide and Robust A1C Reductions Among People With Type 2 Diabetes Requiring Appetite Control: A Review of Two Cases.
    Pitts MA; Griggs RH; Hall MR; Tankersley MS; Johnson JL
    Diabetes Spectr; 2024; 37(2):175-179. PubMed ID: 38756434
    [No Abstract]   [Full Text] [Related]  

  • 13. Liraglutide (victoza): the first once-daily incretin mimetic injection for type-2 diabetes.
    Jackson SH; Martin TS; Jones JD; Seal D; Emanuel F
    P T; 2010 Sep; 35(9):498-529. PubMed ID: 20975808
    [No Abstract]   [Full Text] [Related]  

  • 14. Lira and Naimi Respond.
    Lira MC; Naimi TS
    Am J Public Health; 2022 Apr; 112(4):e2-e3. PubMed ID: 35319945
    [No Abstract]   [Full Text] [Related]  

  • 15. Real-world clinical and economic outcomes of liraglutide versus sitagliptin in patients with type 2 diabetes mellitus in the United States.
    Li Q; Chitnis A; Hammer M; Langer J
    Diabetes Ther; 2014 Dec; 5(2):579-90. PubMed ID: 25256818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and Persistence with Liraglutide Among Patients with Type 2 Diabetes in Routine Clinical Practice--EVIDENCE: A Prospective, 2-Year Follow-Up, Observational, Post-Marketing Study.
    Gautier JF; Martinez L; Penfornis A; Eschwège E; Charpentier G; Huret B; Madani S; Gourdy P
    Adv Ther; 2015 Sep; 32(9):838-53. PubMed ID: 26424330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effectiveness of liraglutide and sitagliptin in type 2 diabetes: a retrospective study in UK primary care.
    Nyeland ME; Ploug UJ; Richards A; Garcia Alvarez L; Demuth D; Muthutantri A; Skovgaard R; Evans M
    Int J Clin Pract; 2015 Mar; 69(3):281-91. PubMed ID: 25302822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece.
    Tzanetakos C; Melidonis A; Verras C; Kourlaba G; Maniadakis N
    BMC Health Serv Res; 2014 Sep; 14():419. PubMed ID: 25245666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of liraglutide in a real-life cohort.
    Heymann A; Maor Y; Goldstein I; Todorova L; Schertz-Sternberg P; Karasik A
    Diabetes Ther; 2014 Jun; 5(1):193-206. PubMed ID: 24664620
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.